Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing Klebsiella pneumoniae From Patients Without Ceftazidime-Avibactam Use History – A Multicenter Study in China

KPC-producing Klebsiella pneumoniae (KPC-KP) is the most widely spread carbapenem-resistant Enterobacteriaceae (CRE) in China. Avibactam is a novel non-β-lactam β-lactamase inhibitor which is highly active against KPC. Recently, ceftazidime-avibactam (CAZ-AVI) was approved for clinical treatment in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Microbiol
Glavni autori: Cui, Xiaoyan, Shan, Bin, Zhang, Xue, Qu, Fen, Jia, Wei, Huang, Bin, Yu, Hua, Tang, Yi-Wei, Chen, Liang, Du, Hong
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Microbiology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7324628/
https://ncbi.nlm.nih.gov/pubmed/32655534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2020.01365
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items